Covalon Showcases Compassionate Pediatric Care Solutions at forty seventh APHON Conference

Sep 19, 2023 | blog

Article content material

Visit Covalon at sales space 425 on the Annual Association of Pediatric Hematology/Oncology Nurses Conference and Exhibit in Cleveland, Ohio to find compassionate an infection prevention expertise designed for youngsters

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a sophisticated medical applied sciences firm, in the present day introduced its participation within the 47th annual Association of Pediatric Hematology/Oncology Nurses (“APHON”) Conference and Exhibit, to be held in Cleveland, Ohio from Thursday, September 21 to Saturday, September 23, 2023. Covalon invitations all attendees to sales space 425 on the Huntington Convention Center, the place they’ll discover our compassionate an infection prevention options tailor made for pediatric sufferers.

Article content material

“9 of the top 10 US pediatric cancer treatment hospitals now use Covalon’s technology.”

“At Covalon, we deeply believe that healing shouldn’t hurt,” stated Ron Hebert, Senior Vice President, Marketing, Covalon. “We understand that nurses, our frontline heroes, require the best tools to deliver the most compassionate care, which is one of the reasons 9 of the top 10 US pediatric cancer treatment hospitals now use Covalon’s technology. We’re proud to introduce our advanced vascular access solutions and dressings to attendees of the APHON Conference.”

The APHON Conference serves as a nexus for the brightest minds in pediatric hematology/oncology nursing. Attendees can have the chance to attach with international leaders, earn persevering with schooling credit, and discover ground-breaking analysis and new expertise.

Covalon’s patented an infection prevention and wound care merchandise embrace:

  • VALGuard® – a clear, environmental barrier designed to guard catheter hubs and line connections from exterior contaminants and gross contamination, together with physique fluids and different secretions. It incorporates a quick-release pull strip for quick entry to infusion hubs and for straightforward elimination.
  • SurgiClear® – the world’s solely dual-antimicrobial clear postoperative dressing that gives full surgical website visibility, permitting for visible website inspection and thus eliminating the necessity for early and a number of dressing removals.
  • IV Clear® – the world’s solely dual-antimicrobial vascular entry dressing that gives full transparency at and across the insertion website for straightforward each day evaluation. It additionally makes use of gentle silicone adhesive expertise to reduce pores and skin accidents and protect pores and skin barrier capabilities, and incorporates protected quantities of antimicrobials, with out sacrificing efficacy, to guard towards chemical irritation.

To guide an appointment with a Covalon consultant, please e-mail Ron Hebert, SVP Marketing, Covalon Technologies Ltd., at

Conference Details

Dates: September 21 – 23, 2023
Location: Huntington Convention Center (300 Lakeside Ave. E, Cleveland, OH 44113, United States)
Register at:

For healthcare suppliers who should not capable of attend the convention however are taken with studying extra about Covalon’s options, go to or observe Covalon on LinkedIn, Facebook, Instagram or Twitter.

Article content material

About Covalon

Covalon Technologies Ltd. is a patient-driven medical machine firm, constructed on the relentless pursuit to assist probably the most susceptible sufferers have a greater likelihood at therapeutic. Through a powerful portfolio of patented applied sciences and options for superior wound care, an infection prevention, and medical machine coatings, we provide progressive, gentler, and extra compassionate choices for sufferers to heal with much less infections, much less ache, and higher outcomes. Our options are designed for sufferers and made for care suppliers. Covalon leverages its patented medical expertise platforms and experience in two methods: (i) by creating merchandise which can be bought below Covalon’s title; and (ii) by creating and commercializing medical merchandise for different medical firms below growth and license contracts. The Company is listed on the TSX Venture Exchange, having the image COV and trades on the OTCQX Market below the image CVALF. To study extra about Covalon, go to our web site at

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that time period is outlined within the insurance policies of the TSX Venture Exchange) accepts duty for the adequacy or accuracy of this launch.

This information launch could include forward-looking statements which replicate the Company’s present expectations concerning future occasions. The forward-looking statements are sometimes, however not at all times, recognized by means of phrases akin to “seek”, “anticipate”, “plan, “estimate”, “expect”, “intend”, or variations of such phrases and phrases or state that sure actions, occasions, or outcomes “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur”, or “be achieved”. In addition, any statements that discuss with expectations, projections or different characterizations of future occasions or circumstances include forward-looking data. Statements containing forward-looking data should not historic details, however as a substitute characterize administration’s expectations, estimates, and projections concerning future occasions. Forward-looking statements contain dangers and uncertainties, together with, however not restricted to, the elements described in higher element within the “Risks and Uncertainties” part of our administration’s dialogue and evaluation of economic situation and outcomes of operations for the 12 months ended September 30, 2022, which is accessible on the Company’s profile at, any of which might trigger outcomes, efficiency, or achievements to vary materially from the outcomes mentioned or implied within the forward-looking statements. Investors shouldn’t place undue reliance on any forward-looking statements. The forward-looking statements contained on this information launch are made as of the date of this information launch, and the Company assumes no obligation to replace or alter any forward-looking statements, whether or not because of new data, additional occasions, or in any other case, besides as required by regulation.

View supply model on



To study extra about Covalon, please contact:
Brian Pedlar, CEO, Covalon Technologies Ltd.
Phone: 905.568.8400 x 233
Toll-Free: 1.877.711.6055
Twitter: @covalon

MoneyMaker FX EA Trading Robot

powered by